The Development of a Floating Drug-Delivery System for Metronidazole - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

The Development of a Floating Drug-Delivery System for Metronidazole
The authors developed a metronidazole-based floating drug-delivery system to investigate the effect of rate-controlling polymers on release pattern and duration of buoyancy in matrix tablets.


Pharmaceutical Technology
pp. 41-44

References

1. A.A. Deshpande et al., Pharm. Res. 14 (6), 815–819 (1997).

2. F. Stops et al., Int. J. Pharm. 308 (1–2), 8–13 (2006).

3. F. Stops et al., Int. J. Pharm. 308 (1–2), 14–24 (2006).

4. S.C. Sweetman, "Biowaiver Monographs for Immediate Release Solid Oral Dosage Forms: Metronidazole," in The Complete Drug Reference, C.F. Rediguieri et al., Eds. (Pharmaceutical Press, London, 36th ed., 2009), pp. 837–841.

5. J.S. Simms-Cendan, J. Infect. Dis. 3 (5), 153–156 (1996).

6. J.W. Tracy and L.T. Webster, Jr., "Drugs Used in the Chemotherapy of Protozoal Infections," in The Pharmacological Basis of Therapeutics, J.G. Hardman, L.E. Limbird, and A.G. Gilman, Eds. (McGraw-Hill, New York, 10th ed., 2001), pp. 1105–1109.

7. K.C. Lamp et al., Clin. Pharmacokinet. 36 (5), 353–373 (1999).

8. E.D. Ralph et al., Antimicrob. Agents Chemother. 6 (6), 691–696 (1974).

9. B.N. Singh and K.H. Kim, J. Control Release 63 (3), 235–259 (2000).

10. S. Burton et al., J. Pharm. Pharmacol. 47 (11), 901–906 (1995).

11. V. Alvisi et al., Drugs Exp. Clin. Res. 22 (1), 29–33 (1996).

12. M. Rahman et al., J. Pharmaceutics Cosmetol. 1 (2), 81–92 (2011).

13. M.D. Chavanpatil et al., Int. J. Pharm. 316 (1–2), 86–92 (2006).

14. T. Higuchi, J. Pharm. Sci. 52 (12), 1145–1149 (1963).

15. S. Asnaashari et al., Pharm. Dev. Technol. 16 (4), 1–8 (2010).


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
30%
Attracting a skilled workforce
27%
Obtaining/maintaining adequate financing
14%
Regulatory compliance
30%
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatcchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
Medicare Payment Data Raises Questions About Drug Costs
FDA Wants You!
A New Strategy to Tackle Antibiotic Resistance
Drug-Diagnostic Development Stymied by Payer Concerns
Obama Administration Halts Attack on Medicare Drug Plans
Source: Pharmaceutical Technology,
Click here